[HTML][HTML] Recent advances in management of COVID-19: A review

S Mouffak, Q Shubbar, E Saleh, R El-Awady - Biomedicine & …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …

COVID-19: A review of the proposed pharmacological treatments

S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …

Drugs for COVID-19: An update

J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …

[HTML][HTML] Medical management of COVID-19: evidence and experience

S Bose, S Adapa, NR Aeddula, S Roy… - Journal of clinical …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …

Clinical management of COVID-19: a review of pharmacological treatment options

AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …

[HTML][HTML] An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics

D Wang, Z Li, Y Liu - Journal of infection and public health, 2020 - Elsevier
Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease-
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …

An update on current therapeutic drugs treating COVID-19

R Wu, L Wang, HCD Kuo, A Shannar, R Peter… - Current pharmacology …, 2020 - Springer
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …

Potential therapeutic options for COVID-19: current status, challenges, and future perspectives

C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …

Current understanding of COVID-19 clinical course and investigational treatments

RB Aguilar, P Hardigan, B Mayi, D Sider… - Frontiers in …, 2020 - frontiersin.org
Importance: Currently, there is no unified framework linking disease progression to
established viral levels, clinical tests, inflammatory markers, and investigational treatment …

Current treatments and therapeutic options for COVID-19 patients: a systematic review

E Mehraeen, Z Najafi, B Hayati… - … Current Drug Targets …, 2022 - ingentaconnect.com
Introduction: COVID-19 is the third rising epidemic in the 21st century that quickly turned into
a worldwide pandemic. Many clinical studies have been achieved to investigate treatments …